NCT04350021View on ClinicalTrials.gov

Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Breast Cancer MetastaticChemotherapy Effect
Interventions
DRUG

Capecitabine, Cyclophosphamide

Capecitabine 500 mg times three, Cyclophosphamide 50 mg once daily

Trial Locations (1)

405 83

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Vastra Gotaland Region

OTHER_GOV

NCT04350021 - Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter